About the Journal

Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published in Diabetes.

Info. and Statistics

Acceptance rate: 12.39%
Frequency: monthly
Impact factor (2019): 9.461
Indexed by: Medline/PubMed, PubMed Central, European PubMed, Scopus, EBSCO
Launch date: 1952
Lead times: Average time to first decision: 14 days; Average time from acceptance to first publication: 10 days
ISSN: Print 0012-1797; Online 1939-327X

Diabetes Online

In order to make original research available faster than traditional print publishing allows, articles accepted for publication in Diabetes are published online ahead of print 3–5 days after acceptance. Online Ahead of Print articles are citable by DOI. DOIs for ADA journals articles begin with 10.2337, followed by the article number assigned when the manuscript was submitted online via the manuscript submission system (e.g., 10.2337/db16-1234).

Free Access

All articles become freely accessible 12 months after the print publication date. In addition, the following are freely available immediately upon publication:

ADA-authored articles, including the annual Scientific Sessions Abstract supplement
Commentaries
Symposia articles
Invited articles
Online-only letters
In This Issue article summaries
Supplemental material
Errata and retractions
Addenda

The access icons found to the right of the article title on the article page, table of contents, and search result views indicate whether the article is freely available () or accessible with an active subscription () / available for purchase ().

Privacy Policy

For information about ADA's information practices and the choices you can make about the way your information is collected and used by ADA, please refer to ADA’s Privacy Policy.

Copyright and Public Access

The American Diabetes Association holds copyright on all content published in ADA journals, unless otherwise noted. Readers may use the content as long as the work is properly cited and linked to the original source, the use is educational and not for profit, and the work is not altered. Articles may not be included without ADA permission in educational materials that are sold to students or used in courses for which tuition or other fees are charged.

Postprints

Immediately upon acceptance, authors are permitted to submit the accepted version of their manuscript (also known as the “Author Accepted Manuscript,” or AAM), with a CC BY license or a CC BY-ND license if required, to their funding body or institution for inclusion in their funding body or institution's database, archive, or designated repository (such as PubMed Central). The AAM is the version of the paper accepted for publication after changes resulting from peer review, but before editing, formatting, and production of the final PDF by ADA staff. For details see:  Copyright Notice and Public Access Policy.

National Institutes of Health

As a courtesy to authors, the final print versions of articles funded by the National Institutes of Health (NIH) are deposited in PubMed Central (PMC) at no cost. In compliance with the NIH policy, these articles will appear on PMC 12 months after print publication in Diabetes Care, Diabetes, Clinical Diabetes, and Diabetes Spectrum.

All articles, regardless of funding body, are delivered to PubMed for inclusion in the PubMed index.

Open Choice

Diabetes offers an “Open Choice” option for authors who wish to make their final published article immediately accessible to nonsubscribers. By paying an additional article-processing charge, authors may elect to have their articles freely available on the journal's website immediately after the final version of the article is published online and in print. Upon receipt of payment and on behalf of the author, ADA will also deposit the final version of the published paper into PubMed Central. For details regarding article-processing charges, see the Instructions for Authors.

ADA Professional Publications Personnel and Contacts

ADA professional publications include books, clinical compendia, scholarly journals, professional news, podcasts, and multimedia.

For a list of the professional publications team members, visit https://diabetesjournals.org/pages/contact.